Keywords:
endometrial hyperplasia, precancerous conditions, hyperestrogenism.References
Apostolou G, Apostolou N, Biteli M, Kavantzas N, Patsouris E, Athanassiadou P. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology. Diagn Cytopathol. - 2014 - Vol.42(2). – Р. 134-42. doi: 10.1002/dc.23010.
Bayard F., Damilano S., Roler P. Cytoplasmic and nuclear estradiol receptors in human endometrium // J. Clin.Endocrinol. and Metabol. – 2018. - Vol 46, №4. – Р. 635-648.
Вodriguez M., Lethaby A., Farquhar C., Duffy J.M. Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews // Cochrane Database Syst Rev. – 2020. – Vol.7 (7). – P.123-135.
Bradley L., Gueye N. The medical management of abnormal uterine bleeding in reproductive-aged women. American J Obstet Gynecol. 2016; 214: 31–44.
Cabanne F. Cancer et lesions precancereuses de l′endometre // Horm. Reprod. Metab. – 2014. - Vol.1, №4. - Р. 15-26.
Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. Therapeutic options for management of endometrial hyperplasia // J Gynecol Oncol. – 2016. - Vol. 27(1). – P. e8. doi: 10.3802/jgo. 2016.27.e8.
Critchley HOD, Babayev E, Bulun SE, Clark S, Garcia-Grau I, Gregersen PK, Kilcoyne A, Kim JJ, Lavender M, Marsh EE, Matteson KA, Maybin JA, Metz CN, Moreno I, Silk K, Sommer M, Simon C, Tariyal R, Taylor HS, Wagner GP, Griffith LG. Menstruation: science and society // Am J Obstet Gynecol. – 2020. - Vol.223(5). – P. 624-664. doi: 10.1016/j.ajog.2020.06.004.
Critchley HOD, Maybin JA, Armstrong GM, Williams ARW. Physiology of the Endometrium and Regulation of Menstruation // Physiol Rev. – 2020. - Vol.100(3). – P. 1149-1179. doi: 10.1152/physrev.00031.2019.
Dutta M, Subramani E, Taunk K, Gajbhiye A, Seal S, Pendharkar N, Dhali S, Ray CD, Lodh I, Chakravarty B, Dasgupta S, Rapole S, Chaudhury K. Investigation of serum proteome alterations in human endometriosis // J Proteomics. – 2015. – Р. 114:182-96. doi: 10.1016/j.jprot.2014.10.021.
Hsieh Y. Y., Chang C. C., Tsai F. J. Androgen receptor trinucleotide polymorphism in leiomyoma // J. Assist. Reprod. Genet. - 2020. - Vol. 21, №12. - Р. 453-457.
Kim C. H., Choe H. D., Huh J. Relationship between endometrial estrogen and progesterone receptors and sonographic endometrial appearance in the preovulatory phase // J. Obstet. Gynecol. Res. – 2020. - Vol. 26, №2. – Р. 95-101.
Lili Ge, Guangquan Liu, Kai Hu at all. //A New Risk Index Combining d-Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer from Patients with Abnormal Vaginal Bleeding or Discharge. - 2020. - DOI: 10.1177/1533033819901117
Marnach M., Laughlin-Tommaso S. Evaluation and Management of Abnormal Uterine Bleeding. Mayo Clinic Proceedings. 2019; 94 (2): 326–335.
Mary L Marnach, Shannon K Laughlin-Tommaso. Evaluation and Management of Abnormal Uterine Bleeding. --2018. – P. 242-256.
Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee.Int J Gynaecol Obstet. 2019 Feb;144(2):237. doi: 10.1002/ijgo.12709. Epub 2018 Nov 27. PMID: 30609040 No abstract available.
Pinchuk G. Theory and problems of immunology. – New. York etc.: McGraw – Hill. - 2022. – 318 p.
Royal College of Obstetrician and ginecologists. Management of Endometrial Hyperplasia. Green-Top Guideline No.67. RCOG/BSGE Joint Guideline – February 2016.]
Sanderson P.A., Critchley H.O., Williams A.R., Arends M.J., Saunders PT. New concepts for an old problem: the diagnosis of endometrial hyperplasia // Hum Reprod Update. – 2017. – Vol.23 (2). – P. 232-254.
Sant′Ana de Almeida E. C., Nogueira A. A. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women // Maturitas. – 2019. - Vol. 49, №3. – Р. 229-233.
Shulan Lv , Qing Wang , Yan Li , Lanbo Zhao at all.// A Clinical Comparative Study of Two Different Endometrial Cell Samplers for Evaluation of Endometrial Lesions by Cytopathological Diagnosis. DOI: 10.2017.
Travaglino A., Raffone A., Saccone G., Insabato L., Mollo A., De Placido G., Zullo F. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review // Acta Obstet Gynecol Scand. – 2019. – Vol.98 (9). – P. 1086–1099.
Vereshchahina TV, Boychuk AV, Yakymchuk YB, Nikitina IM, Datsko TV. Morphological changes of the endometrium in hyperplastic process in women of reproductive age // Wiad Lek. – 2021. – Vol.74(3 cz 1). – P. 388-394.
Van der Meer A.C., Hanna L.S. Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia // Clin Obes. -2017. -Vol.7 (1). – P. 54–57.
Wise MR, Jordan V, Lagas A et al. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review // Am J. Obstet Gynecol. – 2016. –Vol.214 (6). – P. 689–97
Xin Li and Ruijin Shao PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma. American Journal of Cancer Reserch. 2019; 4(1): 73-79.
Yanli Zhang, Dong Zhao, Changguo Gong, Fengmei Zhang, Jing He, Wei Zhang, Yulan Zhao, and Jing Sun. Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis. World J Surg Oncol. 2019; 13: 208
Zaino R, Carinelli SG, Ellenson LH et al. Tumours of the uterine Corpus: epithelial Tumours and Precursors. In: Kurman RJ, Carcanglu ML, Herrington CS, Young RH, eds. WHO Classification of Tumours of female reproductive Organs. 4th ed. Lyon: WHO Press. – 2020. - P. 125-126